JD Supra13h
FDA Releases Proposed Front-of-Package Nutrition Labeling Rule
On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...
FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Children at Dublin creche given medication without parents’ signed consent
Children at a Dublin creche were given medication without their parents’ signed consent and sustained injuries that parents were not informed about, an inspection by Tusla has found.
Fierce Healthcare11d
Biden names GLP-1 drugs Ozempic, Wegovy for price negotiation program
The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs Ozempic, Wegovy and Rybelsus, for the ...
Fierce Healthcare13d
DEA proposes long-awaited special registration for telehealth prescribing, with heightened scrutiny for virtual platforms
This is a breaking story. Check back for updates.UPDATED 1:40 p.m. ET | The new notice of proposed rulemaking adheres to ...